Jimmy Lewis

Jimmy Lewis is a highly experienced professional in forecasting and analytics within the biotechnology and healthcare sectors. Currently serving as Director of Forecasting and Analytics at Amgen since May 2019, Jimmy is responsible for the obesity pipeline, specifically AMG 133 (MariTide). Prior roles at Amgen include Director Commercial Forecasting and Senior Manager Commercial Forecasting, where leadership in forecasting for products like Enbrel and Aimovig was demonstrated. Previous experience includes positions at Medtronic as a Commercial Analytics Consultant and at PwC in Health Industries Advisory, where strategic modeling for top biotech companies was a focus. Early career experience involved engineering and product development roles at Cobra PUMA Golf and Acushnet Company, among others. Jimmy holds an MBA from UCLA Anderson School of Management and a Bachelor of Science in Mechanical Engineering from Yale University.